Skip to main content

Advertisement

SpringerLink
Log in

Unlicensed and off-label use of drugs in pediatric surgical units at tertiary care hospitals of Pakistan

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background Unlicensed and off-label prescribing practice is global dilemma around the world. This pioneering study was designed to determine unlicensed and off-label use of drug in surgical wards of tertiary care hospitals of Pakistan. Objective To assess unlicensed and off-label use of drugs in pediatric surgical unit at three tertiary care hospitals in Peshawar, Pakistan. Setting Two government and one private tertiary care hospitals in Pakistan. Method Drug profiles of 895 patients from three different clinical settings were evaluated for unlicensed and off-label use of drugs using Micromedex DRUGDEX. Main outcome measure Characteristics of the unlicensed and off-label drug prescriptions. Result Total of 3168 prescribed drugs were analyzed in this study. Indication (38.7%) and dose (34.8%) were the most frequent off-label categories. In comparison with the corresponding reference categories, infants and children, male patients and having less than five prescribed drugs were significant predictors of unlicensed prescriptions. In comparison with the corresponding reference categories, significant predictors of off-label drug prescribing were children younger than two year, children between 2–12 years, patient staying at hospital less than 5 days and patients having less than five prescribed drugs. Conclusion The prevalence of unlicensed and off-label drug prescriptions are high at pediatric surgical ward of tertiary care hospitals. More awareness of the efficacy and safety of drugs are required in pediatrics. In addition, new formulations with advanced dosing for children are also required to minimize the risk of adverse outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wilson JT. An update on the therapeutic orphan. Pediatrics. 1999;104(Supplement 3):585–90.

    CAS  PubMed  Google Scholar 

  2. Wettermark B, Hammar N, MichaelFored C, Leimanis A, Otterblad Olausson P, Bergman U, et al. The new Swedish Prescribed Drug Register—opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–35.

    Article  PubMed  Google Scholar 

  3. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58(4):323–37.

    Article  PubMed  Google Scholar 

  4. Bellis JR, Kirkham JJ, Thiesen S, Conroy EJ, Bracken LE, Mannix HL, et al. Adverse drug reactions and off-label and unlicensed medicines in children: a nested case? Control study of inpatients in a pediatric hospital. BMC Med. 2013;11(1):1.

    Article  Google Scholar 

  5. Jain SS, Bavdekar S, Gogtay NJ, Sadawarte PA. Off-label drug use in children. Indian J Pediatr. 2008;75(11):1133–6.

    Article  PubMed  Google Scholar 

  6. Di Paolo ER, Stoetter H, Cotting J, Frey P, Gehri M, Beck-Popovic M, et al. Unlicensed and off-label drug use in a Swiss paediatric university hospital. Swiss Med Wkly. 2006;136(13/14):218.

    PubMed  Google Scholar 

  7. Lindell-Osuagwu L, Korhonen M, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H, et al. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther. 2009;34(3):277–87.

    Article  CAS  PubMed  Google Scholar 

  8. Cuzzolin L, Atzei A, Fanos V. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf. 2006;5(5):703–18.

    Article  PubMed  Google Scholar 

  9. Williams JR. The Declaration of Helsinki and public health. Bull World Health Organ. 2008;86(8):650–2.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kimland E, Odlind V. Off-label drug use in pediatric patients. Clin Pharmacol Ther. 2012;91(5):796–801.

    Article  CAS  PubMed  Google Scholar 

  11. Czaja AS, Valuck R. Off-label antidepressant use in children and adolescents compared with young adults: extent and level of evidence. Pharmacoepidemiol Drug Saf. 2012;21(9):997–1004.

    Article  PubMed  Google Scholar 

  12. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ. 2000;320(7227):79–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Saiyed MM, Lalwani T, Rana D. Off-label medicine use in pediatric inpatients: a prospective observational study at a tertiary care hospital in India. Int J Pediatr. 2014. doi:10.1155/2014/415815

  14. Cuzzolin L, Zaccaron A, Fanos V. Unlicensed and off-label uses of drugs in paediatrics: a review of the literature. Fundam Clin Pharmacol. 2003;17(1):125–31.

    Article  CAS  PubMed  Google Scholar 

  15. Al Khaja KA, Al Ansari TM, Damanhori AH, Sequeira RP. Evaluation of drug utilization and prescribing errors in infants: a primary care prescription-based study. Health Policy. 2007;81(2):350–7.

    Article  PubMed  Google Scholar 

  16. Dos Santos L, Heineck I. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications. Farm Hosp. 2012;36(4):180–6.

    Article  PubMed  Google Scholar 

  17. Langerová P, Vrtal J, Urbánek K. Incidence of unlicensed and off-label prescription in children. Ital J Pediatr. 2014;40(1):1.

    Article  Google Scholar 

  18. Corny J, Lebel D, Bailey B, Bussières J-F. Unlicensed and off-label drug use in children before and after pediatric governmental initiatives. J Pediatr Pharmacol Ther. 2015;20(4):316–28.

    PubMed  PubMed Central  Google Scholar 

  19. Czarniak P, Bint L, Favié L, Parsons R, Hughes J, Sunderland B, et al. Clinical setting influences off-label and unlicensed prescribing in a paediatric teaching hospital. PLoS ONE. 2015;10(3):e0120630.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Magalhães J, Rodrigues AT, Roque F, Figueiras A, Falcão A, Herdeiro MT, et al. Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review. Eur J Clin Pharmacol. 2015;71(1):1–13.

    Article  PubMed  Google Scholar 

  21. Hsien L, Breddemann A, Frobel A-K, Heusch A, Schmidt KG, Läer S, et al. Off-label drug use among hospitalised children: identifying areas with the highest need for research. Pharm World Sci. 2008;30(5):497–502.

    Article  PubMed  Google Scholar 

  22. Teigen A, Wang S, Truong BT, Bjerknes K. Off‐label and unlicensed medicines to hospitalised children in Norway. J Pharm Pharmacol. 2017;69(4):432–8.

  23. Lindell-Osuagwu L, Hakkarainen M, Sepponen K, Vainio K, Naaranlahti T, Kokki H, et al. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation. J Clin Pharm Ther. 2014;39(2):144–53.

    Article  CAS  PubMed  Google Scholar 

  24. Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ. 1998;316(7128):343–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Turner S, Nunn A, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr. 1999;88(9):965–8.

    Article  CAS  PubMed  Google Scholar 

  26. Khdour MR, Hallak HO, Alayasa KSAA, AlShahed QN, Hawwa AF, McElnay JC, et al. Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine. Int J Clin Pharm. 2011;33(4):650–5.

    Article  PubMed  Google Scholar 

  27. Sammons H, Choonara I. Clinical trials of medication in children, 1996–2002. Eur J Clin Pharmacol. 2005;61(2):165–7.

    Article  CAS  PubMed  Google Scholar 

  28. Food and Drug Administration. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients. Fed Regist. 1998;63(231):66631–72.

    Google Scholar 

  29. Pandolfini C, Bonati M, Sammons H, Choonara I, Jacqz-Aigrain E, Danes I, et al. A European clinical trials registry for children. Paediatr Perinat Dr Ther. 2003;5:98–100.

    Article  Google Scholar 

Download references

Acknowledgements

Special thanks to the Directorate of Science and Technology, Khyber Pakhtunkhwa, for their support through the provision of Micromedex DRUGDEX database.

Author information

Authors and Affiliations

  1. Department of Pharmacy, University of Peshawar, Peshawar, Pakistan

    Muhammad Aamir & Jamshaid Ali Khan

  2. Department of Pharmacy, Sarhad University of Science and Information Technology, Peshawar, Pakistan

    Faisal Shakeel

  3. Department of Statistics, University of Peshawar, Peshawar, Pakistan

    Syed Muhammad Asim

Authors
  1. Muhammad Aamir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jamshaid Ali Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Faisal Shakeel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Syed Muhammad Asim
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Funding

None.

Corresponding author

Correspondence to Jamshaid Ali Khan.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aamir, M., Khan, J.A., Shakeel, F. et al. Unlicensed and off-label use of drugs in pediatric surgical units at tertiary care hospitals of Pakistan. Int J Clin Pharm 39, 860–866 (2017). https://doi.org/10.1007/s11096-017-0485-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-017-0485-8

Keywords

Search

Navigation